Wai Keen Chung (Wai K Chung)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Monoclonal Antibody

Liquid Chromatography

Molecular Dynamics Simulations

Binding Protein

Top Venues

Biotechnology and bioengineering

Biotechnology progress

This page only lists publications with an associated author ORCID identifier.

Publications

Siddharth S Parasnavis, Ben Niu, Matthew Aspelund, Wai Keen Chung, Mark Snyder, Steven M Cramer
Systematic workflow for studying domain contributions of bispecific antibodies to selectivity in multimodal chromatography. Biotechnology and bioengineering 119 (1) (2021)
Nicole Swope, Wai Keen Chung, Mingyan Cao, Dana Motabar, Dengfeng Liu, Sanjeev Ahuja, Michael W Handlogten
Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation. Biotechnology and bioengineering 117 (4) (2020)
Swarnim Ranjan, Wai Keen Chung, Min Zhu, David Robbins, Steven M Cramer
Implementation of an experimental and computational tool set to study protein-mAb interactions. Biotechnology progress 35 (4) (2019)
Swarnim Ranjan, Wai Keen Chung, Romina Hofele, Jenny Heidbrink Thompson, Jared Bee, Limin Zhang, David Robbins, Steven M Cramer
Investigation of cathepsin D-mAb interactions using a combined experimental and computational tool set. Biotechnology and bioengineering 116 (7) (2019)
Cassia Andrade, Lindsay Arnold, Dana Motabar, Matthew Aspelund, Alison Tang, Alan Hunter, Wai Keen Chung
An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process. Biotechnology progress 35 (1) (2018)
Wai Keen Chung, Brian Russell, Yanhong Yang, Michael Handlogten, Suzanne Hudak, Mingyan Cao, Jihong Wang, David Robbins, Sanjeev Ahuja, Min Zhu
Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability. Biotechnology and bioengineering 114 (6) (2017)